NUNZIA PHARMACEUTICAL COMPANY Increase (Decrease) in Accounts Payable and Accrued Liabilities
NUNZIA PHARMACEUTICAL COMPANY reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $41.49 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2022-11-14
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2022-09-30 was $35.97K.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-09-30 was -$14.63K, a 838.09% decline year-over-year.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-06-30 was $1.39K, a 3.74% increase year-over-year.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2021-03-31 was -$1.39K, a 1372.48% decline year-over-year.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $4.54K, a 47.53% decline from fiscal 2019.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $8.64K, a 313.54% increase from fiscal 2018.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $2.09K, a 83.15% decline from fiscal 2017.
- NUNZIA PHARMACEUTICAL COMPANY increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $12.40K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|
| 2022-09-30 | $35.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $41.49K 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | $5.52K 10-Q · filed 2022-10-03 | |||||
| 2021-09-30 | -$14.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$13.24K derived: sum of 2 quarters · filed 2022-11-14 | -$14.63K 10-Q · filed 2022-11-14 | -$13.52K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-03 | $0.00 10-Q · filed 2022-10-03 | $126.00 10-Q · filed 2021-09-17 | $1.11K derived: sum of 3 quarters · filed 2022-10-03 | $3.09K derived: sum of 4 quarters · filed 2022-10-03 | |
| 2021-03-31 | -$1.39K 10-Q · filed 2021-09-17 | -$280.00 derived: sum of 2 quarters · filed 2022-03-29 | $1.70K derived: sum of 3 quarters · filed 2022-03-29 | $3.04K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-12-31 | $1.11K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-29 | $3.09K derived: sum of 2 quarters · filed 2022-03-29 | $4.43K derived: sum of 3 quarters · filed 2022-03-29 | $4.54K 10-K/A · filed 2022-03-29 | ||
| 2020-09-30 | $1.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $3.32K derived: sum of 2 quarters · filed 2021-11-10 | $3.43K 10-Q · filed 2021-11-10 | $6.65K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-06-30 | $1.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-17 | $1.45K 10-Q · filed 2021-09-17 | $4.67K derived: sum of 3 quarters · filed 2022-03-29 | $5.98K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2020-03-31 | $109.00 10-Q · filed 2021-09-17 | $3.33K derived: sum of 2 quarters · filed 2022-03-29 | $4.64K derived: sum of 3 quarters · filed 2022-03-29 | $7.95K derived: sum of 4 quarters · filed 2022-03-29 | ||
| 2019-12-31 | $3.22K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-29 | $4.53K derived: sum of 2 quarters · filed 2022-03-29 | $7.84K derived: sum of 3 quarters · filed 2022-03-29 | $8.64K 10-K/A · filed 2022-03-29 | ||
| 2019-09-30 | $1.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-16 | $4.61K derived: sum of 2 quarters · filed 2021-09-16 | $5.42K 10-Q · filed 2021-09-16 | $2.92K 10-Q · filed 2019-12-02 | $14.82K derived: sum of 4 quarters · filed 2021-09-16 | |
| 2019-06-30 | $3.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-16 | $4.11K 10-Q · filed 2021-09-16 | $1.61K 10-Q · filed 2019-09-18 | $13.52K derived: sum of 3 quarters · filed 2021-09-16 | $14.32K derived: sum of 4 quarters · filed 2021-09-16 | |
| 2019-03-31 | $807.00 10-Q · filed 2021-09-16 | $10.21K derived: sum of 2 quarters · filed 2021-09-16 | $11.02K derived: sum of 3 quarters · filed 2021-09-16 | $3.23K derived: sum of 4 quarters · filed 2021-09-16 | ||
| 2018-12-31 | $9.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-31 | $10.21K derived: sum of 2 quarters · filed 2019-12-02 | $2.42K derived: sum of 3 quarters · filed 2019-12-02 | $2.09K 10-K · filed 2019-05-31 | ||
| 2018-09-30 | $807.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-12-02 | -$6.98K derived: sum of 2 quarters · filed 2019-12-02 | -$7.31K 10-Q · filed 2019-12-02 | |||
| 2018-06-30 | -$7.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-09-18 | -$8.12K 10-Q · filed 2019-09-18 | ||||
| 2018-03-31 | -$331.00 10-Q · filed 2019-05-31 | |||||
| 2017-12-31 | $12.40K 10-K · filed 2019-05-31 | |||||
| 2015-12-31 | $750.00 10-K · filed 2019-05-31 | |||||
| 2014-12-31 | $3.71K 10-K · filed 2019-05-31 | |||||
| 2013-12-31 | $3.73K 10-K · filed 2019-05-31 | |||||
| 2012-12-31 | $4.11K 10-K · filed 2019-05-31 | |||||
| 2011-12-31 | $3.96K 10-K · filed 2019-05-31 | |||||
| 2010-12-31 | $40.34K 10-K · filed 2019-05-31 |